In contrast, KLF6 was able to transactivate multiple genes that negatively regulated the NF-κB pathway, thereby decreasing the nuclear localization of NF-κB and downregulating the expression of its target genes in glioblastoma [29]. Here, KLF6 is linked to glioblastoma.